Forecasting COVID-19 recovered cases with Artificial Neural Networks to enable designing an effective blood supply chain.

Artificial neural networks Blood supply chain CIP Therapy COVID-19 Forecasting

Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
12 2021
Historique:
received: 03 08 2021
revised: 08 11 2021
accepted: 10 11 2021
pubmed: 19 11 2021
medline: 15 12 2021
entrez: 18 11 2021
Statut: ppublish

Résumé

This study introduces a forecasting model to help design an effective blood supply chain mechanism for tackling the COVID-19 pandemic. In doing so, first, the number of people recovered from COVID-19 is forecasted using the Artificial Neural Networks (ANNs) to determine potential donors for convalescent (immune) plasma (CIP) treatment of COVID-19. This is performed explicitly to show the applicability of ANNs in forecasting the daily number of patients recovered from COVID-19. Second, the ANNs-based approach is further applied to the data from Italy to confirm its robustness in other geographical contexts. Finally, to evaluate its forecasting accuracy, the proposed Multi-Layer Perceptron (MLP) approach is compared with other traditional models, including Autoregressive Integrated Moving Average (ARIMA), Long Short-term Memory (LSTM), and Nonlinear Autoregressive Network with Exogenous Inputs (NARX). Compared to the ARIMA, LSTM, and NARX, the MLP-based model is found to perform better in forecasting the number of people recovered from COVID-19. Overall, the findings suggest that the proposed model is robust and can be widely applied in other parts of the world in forecasting the patients recovered from COVID-19.

Identifiants

pubmed: 34794082
pii: S0010-4825(21)00823-4
doi: 10.1016/j.compbiomed.2021.105029
pmc: PMC8590479
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105029

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Ertugrul Ayyildiz (E)

Department of Industrial Engineering, Karadeniz Technical University, Ortahisar, 61080, Trabzon, Turkey; Department of Industrial Engineering, Yildiz Technical University, Beşiktaş, 34349, İstanbul, Turkey. Electronic address: ertugrulayyildiz@ktu.edu.tr.

Melike Erdogan (M)

Department of Industrial Engineering, Duzce University, Konuralp, 81620, Duzce, Turkey.

Alev Taskin (A)

Department of Industrial Engineering, Yildiz Technical University, Beşiktaş, 34349, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH